Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

PURPOSE: The oligometastatic paradigm hypothesizes that patients with a limited number of metastases may achieve long-term disease control, or even cure, if all sites of disease can be ablated. However, long-term randomized data that test this paradigm are lacking. METHODS: We enrolled patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Palma, David A., Olson, Robert, Harrow, Stephen, Gaede, Stewart, Louie, Alexander V., Haasbeek, Cornelis, Mulroy, Liam, Lock, Michael, Rodrigues, George B., Yaremko, Brian P., Schellenberg, Devin, Ahmad, Belal, Senthi, Sashendra, Swaminath, Anand, Kopek, Neil, Liu, Mitchell, Moore, Karen, Currie, Suzanne, Schlijper, Roel, Bauman, Glenn S., Laba, Joanna, Qu, X. Melody, Warner, Andrew, Senan, Suresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
RAPID COMMUNICATIONS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460150/
https://www.ncbi.nlm.nih.gov/pubmed/32484754
http://dx.doi.org/10.1200/JCO.20.00818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460150/
https://www.ncbi.nlm.nih.gov/pubmed/32484754
http://dx.doi.org/10.1200/JCO.20.00818

Ejemplares similares